Howard G. Welgus sold $253K of Arcutis Biotherapeutics (ARQT)

Executed Nov 3 2025, disclosed Nov 5 2025, 2 days later.

Value, as filed

$253K

10,000 sh × $25.27

Executed

Nov 3 2025

the trade date, as filed

Disclosed

Nov 5 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Howard G. Welgus Director profile →

Howard G. Welgus (Director) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $302K of ARQT (10,000 sh × $30.21, as filed), executed Dec 1 2025.

The name

ARQT

Arcutis Biotherapeutics, Inc. ARQT · Healthcare · 65 filings in 24 months ticker →

Healthcare · Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Howard G. Welgus in ARQT

ARQTSALE Arcutis Biotherapeutics, Inc. $114K
4,730 sh × $24.18
Exec Sep 15
Filed Sep 17 · 4:06 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $124K
4,730 sh × $26.18
Exec Aug 17
Filed Aug 19 · 4:57 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $127K
4,730 sh × $26.91
Exec Jul 15
Filed Jul 17 · 4:01 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $164K
7,144 sh × $22.99
Exec May 1
Filed May 5 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $239K
10,000 sh × $23.88
Exec Apr 1
Filed Apr 3 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $256K
10,000 sh × $25.65
Exec Mar 2
Filed Mar 4 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $250K
10,000 sh × $25.05
Exec Feb 2
Filed Feb 4 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $290K
10,000 sh × $28.96
Exec Jan 2
Filed Jan 6 · 5:30 PM ET